Contact Person : NYAS Customer Service; Last Date for the submission of abstract : 41733; Description : Examine issues in anti-angiogenic therapy such as inherent/acquired resistance, immunomodulation, enhanced invasiveness, and the lack of validated predictive and prognostic biomarkers. Keynote by Harold F. Dvorak. Apply for travel fellowships by 4/4.